Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$596M |
| 2 |
Meta Platforms (Facebook)
META
|
+$524M |
| 3 |
Microsoft
MSFT
|
+$415M |
| 4 |
Dominion Energy
D
|
+$358M |
| 5 |
Amazon
AMZN
|
+$358M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HEICO Corp Class A
HEI.A
|
+$764M |
| 2 |
Vale
VALE
|
+$427M |
| 3 |
SIVB
SVB Financial Group
SIVB
|
+$397M |
| 4 |
NBIS
Nebius Group N.V.
NBIS
|
+$376M |
| 5 |
ONC
BeOne Medicines Ltd
ONC
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.68% |
| 2 | Healthcare | 12.92% |
| 3 | Financials | 11.76% |
| 4 | Industrials | 11.1% |
| 5 | Consumer Discretionary | 10.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2976
KB Financial Group
KB
$41.7B
| $726K | ﹤0.01% |
19,942
+861
| +5% | +$35.6K |
|
2977
Atea Pharmaceuticals
AVIR
$406M
| $726K | ﹤0.01% |
216,774
+68,845
| +47% | +$279K |
|
2978
BHP
BHP
$222B
| $723K | ﹤0.01% |
11,400
+2,453
| +27% | +$158K |
|
2979
iShares Core S&P Small-Cap ETF
IJR
$113B
| $722K | ﹤0.01% |
7,464
-464
| -6% | -$46.4K |
|
2980
Takeda Pharmaceutical
TAK
$55.5B
| $720K | ﹤0.01% |
+43,710
| New | +$696K |
|
|
DBD
2981
DELISTED
Diebold Nixdorf Incorporated
DBD
| $720K | ﹤0.01% |
599,609
+108,867
| +22% | +$242K |
|
2982
Rocket Lab Corp
RKLB
$51.2B
| $718K | ﹤0.01% |
177,825
+94,617
| +114% | +$425K |
|
2983
Astronics
ATRO
$4.57B
| $718K | ﹤0.01% |
64,487
-45,852
| -42% | -$512K |
|
2984
AbCellera Biologics
ABCL
$3.36B
| $718K | ﹤0.01% |
95,208
+17,017
| +22% | +$155K |
|
2985
UWM Holdings
UWMC
$2.61B
| $715K | ﹤0.01% |
145,608
+19,271
| +15% | +$84.5K |
|
|
AKRO
2986
DELISTED
Akero Therapeutics
AKRO
| $714K | ﹤0.01% |
18,653
-184,375
| -91% | -$8.22M |
|
2987
KRONOS Worldwide
KRO
$996M
| $714K | ﹤0.01% |
77,475
+11,426
| +17% | +$120K |
|
|
BVH
2988
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $713K | ﹤0.01% |
26,059
-12,593
| -33% | -$375K |
|
2989
Johnson Outdoors
JOUT
$512M
| $711K | ﹤0.01% |
11,283
-2,012
| -15% | -$130K |
|
|
MUE
2990
DELISTED
BlackRock MuniHoldings Quality Fund II
MUE
| $709K | ﹤0.01% |
70,579
+2,442
| +4% | +$24.7K |
|
|
BORR
2991
Borr Drilling
BORR
$1.25B
| $708K | ﹤0.01% |
93,425
-96,100
| -51% | -$619K |
|
2992
IonQ
IONQ
$18.2B
| $705K | ﹤0.01% |
114,641
+45,764
| +66% | +$214K |
|
2993
Hydrofarm Holdings
HYFM
$8.58M
| $703K | ﹤0.01% |
40,656
+33,731
| +487% | +$597K |
|
2994
Fate Therapeutics
FATE
$294M
| $703K | ﹤0.01% |
123,261
+75,782
| +160% | +$457K |
|
2995
Waterstone Financial
WSBF
$385M
| $701K | ﹤0.01% |
46,361
-52,682
| -53% | -$850K |
|
2996
TH International
THCH
$51.3M
| $701K | ﹤0.01% |
+34,448
| New | +$694K |
|
|
IMGN
2997
DELISTED
Immunogen Inc
IMGN
| $699K | ﹤0.01% |
182,068
+90,988
| +100% | +$388K |
|
2998
Rocket Pharmaceuticals
RCKT
$367M
| $699K | ﹤0.01% |
40,795
-67,582
| -62% | -$1.32M |
|
|
IBA
2999
DELISTED
Industrias Bachoco SAB De C.V.
IBA
| $697K | ﹤0.01% |
10,514
-3,154
| -23% | -$172K |
|
3000
Cato Corp
CATO
$66.7M
| $694K | ﹤0.01% |
78,520
-9,646
| -11% | -$91.2K |
|
Similar funds
Invesco's Q1 2023 Portfolio in Review
As of Q1 2023, Invesco held 4,112 positions worth $358B, up 5% from $341B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Invesco's Q1 2023 filing shows 101 new, 1,789 increased, 1,808 reduced and 253 closed positions. Its largest new stake was GE HealthCare: 3,173,709 shares worth $260M. The largest sale was HEICO Corp Class A, an estimated $764M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Invesco's largest Q1 2023 buy was GE HealthCare: 3,173,709 shares worth $260M.
- Invesco added most to Apple in Q1 2023, an estimated $596M increase.
- Invesco's biggest Q1 2023 reduction was HEICO Corp Class A, cutting an estimated $764M.
- Invesco fully exited SVB Financial Group in Q1 2023, selling an estimated $397M.
- Invesco's ten largest holdings make up 13% of its $358B portfolio in Q1 2023.
- Invesco opened 101 new positions and closed 253 in Q1 2023.
- Invesco's portfolio value rose 5% quarter-over-quarter to $358B.
Based on Invesco's 13F filing for Q1 2023, filed 12 May 2023.